{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:53:39Z","timestamp":1781844819757,"version":"3.54.5"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Skin dysbiosis plays a crucial role in inflammatory skin diseases, particularly in genodermatoses such as Netherton syndrome (NS). This case report aimed to investigate changes in the skin microbiome of a patient with Netherton syndrome before and during dupilumab therapy, with the goal of expanding the limited evidence currently available on this topic. We report the case of a 35-year-old woman diagnosed with NS at birth, who, prior to dupilumab therapy, presented with atopic dermatitis (AD), ichthyosis linearis circumflexa, and severe pruritus. Dupilumab therapy was initiated, and skin swabs were collected from lesional sites at three different time points: at baseline, after 1\u202fmonth, and after 1\u202fyear of continuous dupilumab therapy. At baseline, a microbiome analysis revealed low microbial diversity with a predominance of\n                    <jats:italic>Pantoea<\/jats:italic>\n                    and\n                    <jats:italic>Pseudomonas<\/jats:italic>\n                    species. After 1\u202fyear, a significant increase in microbial diversity, with a predominance of\n                    <jats:italic>Staphylococcus<\/jats:italic>\n                    species and an increase in\n                    <jats:italic>Malassezia<\/jats:italic>\n                    species, was observed. Clinically, the patient experienced remission in parallel with these microbiome shifts. Post-treatment, the skin microbiome showed increased microbial diversity and re-establishment of beneficial commensals, more closely resembling healthy skin. The findings of this case report underscore the role of dupilumab in restoring a healthy skin microbiome along with symptomatological and clinical improvement in the genodermatosis Netherton syndrome.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2026.1854027","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:29:45Z","timestamp":1781843385000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of dupilumab in skin microbiome shifts in the Netherton genodermatosis: a case report and review of literature"],"prefix":"10.3389","volume":"13","author":[{"given":"Elena","family":"Campione","sequence":"first","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, Tor Vergata University Hospital","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Simonelli","sequence":"additional","affiliation":[{"name":"Otorinolaryngology Unit, Department of Sense Organs, Policlinico Umberto I University Hospital","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico Salvatore","family":"Pistoia","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Rome Tor Vergata","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terenzio","family":"Cosio","sequence":"additional","affiliation":[{"name":"Department of Basic Biotechnological Sciences, Intensive and Perioperative Clinics, Universit\u00e0 Cattolica del Sacro Cuore","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Artosi","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, Tor Vergata University Hospital","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Diluvio","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, Tor Vergata University Hospital","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, Tor Vergata University Hospital","place":["Rome, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gaziano","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, University of Rome Tor Vergata","place":["Rome, Italy"]},{"name":"Department of Biochemical Sciences, Catholic University \"Our Lady of Good Counsel\"","place":["Tirana, Albania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"645259","DOI":"10.3389\/fped.2021.645259","article-title":"Netherton syndrome in children: management and future perspectives","volume":"9","author":"Barbati","year":"2021","journal-title":"Front Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/15384101.2019.1707455","article-title":"Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo","volume":"19","author":"Campione","year":"2020","journal-title":"Cell Cycle"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/21678707.2020.1857724","article-title":"Advances in understanding of Netherton syndrome and therapeutic implications","volume":"8","author":"Petrova","year":"2020","journal-title":"Expert Opin Orphan Drugs"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"864449","DOI":"10.3389\/fimmu.2022.864449","article-title":"Outcomes of systemic treatment in children and adults with Netherton syndrome: a systematic review","volume":"13","author":"Nouwen","year":"2022","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jaci.2014.07.008","article-title":"IgE allergen component\u2013based profiling and atopic manifestations in patients with Netherton syndrome","volume":"134","author":"Hannula-Jouppi","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1016\/j.celrep.2020.02.021","article-title":"Interplay of staphylococcal and host proteases promotes skin barrier disruption in Netherton syndrome","volume":"30","author":"Williams","year":"2020","journal-title":"Cell Rep"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jid.2020.05.102","article-title":"Initial evidence of distinguishable bacterial and fungal dysbiosis in the skin of patients with atopic dermatitis or Netherton syndrome","volume":"141","author":"Moosbrugger-Martinz","year":"2021","journal-title":"J Invest Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"100008","DOI":"10.1016\/j.xjidi.2021.100008","article-title":"Skin microbiota and clinical associations in Netherton syndrome","volume":"1","author":"Sillanp\u00e4\u00e4","year":"2021","journal-title":"JID Innov"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/bjd.21687","article-title":"Distinct skin microbiome community structures in congenital ichthyosis","volume":"187","author":"Tham","year":"2022","journal-title":"Br J Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archdermatol.2009.326","article-title":"The safety and efficacy of pimecrolimus 1% cream for the treatment of Netherton syndrome: results from an exploratory study","volume":"146","author":"Yan","year":"2010","journal-title":"Arch Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1365-4632.2006.02956.x","article-title":"Netherton syndrome: successful use of topical tacrolimus and pimecrolimus in four siblings","volume":"46","author":"Bin Saif","year":"2007","journal-title":"Int J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2230.2011.04231.x","article-title":"Narrowband ultraviolet B phototherapy associated with improvement in Netherton syndrome","volume":"37","author":"Maatouk","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1468-3083.1995.tb00540.x","article-title":"Netherton\u2019s syndrome in two sisters. A ten year experience of therapy with retinoids","volume":"5","author":"Groves","year":"1995","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/jamadermatol.2020.1019","article-title":"Secukinumab therapy for Netherton syndrome","volume":"156","author":"Luchsinger","year":"2020","journal-title":"JAMA Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1074243","DOI":"10.3389\/fped.2022.1074243","article-title":"Biological treatments for pediatric Netherton syndrome","volume":"10","author":"Pontone","year":"2022","journal-title":"Front Pediatr"},{"key":"ref16","first-page":"266","article-title":"Treatment of Netherton syndrome in pediatrics with upadacitinib","volume":"31","author":"Sun","year":"2025","journal-title":"Altern Ther Health Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/ced.14317","article-title":"Successful treatment with dupilumab of an adult with Netherton syndrome","volume":"45","author":"Andreasen","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajd.13986","article-title":"Long-term dupilumab therapy in Netherton syndrome with severe atopic manifestations: case report and review of the literature","volume":"64","author":"\u00d6zkaya","year":"2023","journal-title":"Australas J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/children9030310","article-title":"Dupilumab improves pruritus in Netherton syndrome: a case study","volume":"9","author":"Inaba","year":"2022","journal-title":"Children (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3390\/biom13040634","article-title":"Dupilumab in inflammatory skin diseases: a systematic review","volume":"13","author":"Olbrich","year":"2023","journal-title":"Biomolecules"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1111\/jdv.16883","article-title":"Response to dupilumab in two children with Netherton syndrome: improvement of pruritus and scaling","volume":"35","author":"S\u00fc\u00dfmuth","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/pde.14362","article-title":"Netherton syndrome: temporary response to dupilumab","volume":"37","author":"Aktas","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/microorganisms12010224","article-title":"Dupilumab alters both the bacterial and fungal skin microbiomes of patients with atopic dermatitis","volume":"12","author":"Umemoto","year":"2024","journal-title":"Microorganisms."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e1060","DOI":"10.1111\/jdv.70006","article-title":"Dupilumab improves skin microbiome in a pediatric case of Netherton syndrome","volume":"39","author":"Nakajima","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.gpb.2016.05.004","article-title":"Oxford Nanopore MinION sequencing and genome assembly","volume":"14","author":"Lu","year":"2016","journal-title":"Genomics Proteomics Bioinform"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.7860\/JCDR\/2013\/5506.3371","article-title":"Pattern of bacterial colonization of atopic dermatitis in Saudi children","volume":"7","author":"Bilal","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/j.ddmec.2012.12.003","article-title":"What lives on our skin: ecology, genomics and therapeutic opportunities of the skin microbiome","volume":"10","author":"Scharschmidt","year":"2013","journal-title":"Drug Discov Today Dis Mech"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/microorganisms12040808","article-title":"Women skin microbiota modifications during pregnancy","volume":"12","author":"Radocchia","year":"2024","journal-title":"Microorganisms."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/mlf2.12064","article-title":"Human skin bacterial microbiota homeostasis: a delicate balance between health and disease","volume":"2","author":"Zhu","year":"2023","journal-title":"mLife"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3390\/microorganisms8111752","article-title":"Staphylococcus epidermidis and Cutibacterium acnes: two major sentinels of skin microbiota and the influence of cosmetics","volume":"8","author":"Fourni\u00e8re","year":"2020","journal-title":"Microorganisms"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12866-021-02302-2","article-title":"Skin dysbiosis in the microbiome in atopic dermatitis is site-specific and involves bacteria, fungus and virus","volume":"21","author":"Bjerre","year":"2021","journal-title":"BMC Microbiol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"102381","DOI":"10.1016\/j.mib.2023.102381","article-title":"The skin mycobiome and intermicrobial interactions in the cutaneous niche","volume":"76","author":"Tuor","year":"2023","journal-title":"Curr Opin Microbiol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"102235","DOI":"10.1016\/j.mib.2022.102235","article-title":"Forgotten fungi: the importance of the skin mycobiome","volume":"70","author":"Nguyen","year":"2022","journal-title":"Curr Opin Microbiol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1348-0421.2011.00364.x","article-title":"Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects","volume":"55","author":"Zhang","year":"2011","journal-title":"Microbiol Immunol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1854027\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:29:46Z","timestamp":1781843386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1854027\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":34,"alternative-id":["10.3389\/fmed.2026.1854027"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1854027","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"article-number":"1854027"}}